+2,371.5%
SMCI vs CVS
+262.8%
+2,108.6%
-84.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -9.2% | +1.0% | -10.2% | -9.5% |
| 7D | -19.4% | -9.5% | -9.9% | -16.5% |
| 30D | -39.1% | -12.9% | -26.3% | -36.3% |
| 3M | -40.7% | -13.1% | -27.6% | -38.2% |
| 6M | -35.3% | -12.2% | -23.1% | -33.2% |
| YTD | -26.0% | +5.0% | -31.0% | -29.4% |
| 1Y | -31.4% | +9.6% | -41.0% | -35.6% |
| 3Y | -28.9% | +32.6% | -61.5% | -41.9% |
| 5Y | +413.3% | +2.6% | +410.7% | +363.0% |
| 10Y | +734.3% | +49.0% | +685.3% | +497.1% |
| All | +2,371.5% | +262.8% | +2,108.6% | +1,058.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling